352 related articles for article (PubMed ID: 23530096)
21. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making.
Anaya DA; Lahat G; Liu J; Xing Y; Cormier JN; Pisters PW; Lev DC; Pollock RE
Ann Surg; 2009 Jan; 249(1):137-42. PubMed ID: 19106689
[TBL] [Abstract][Full Text] [Related]
22. Impact of chemotherapy on survival in surgically resected retroperitoneal sarcoma.
Miura JT; Charlson J; Gamblin TC; Eastwood D; Banerjee A; Johnston FM; Turaga KK
Eur J Surg Oncol; 2015 Oct; 41(10):1386-92. PubMed ID: 26251340
[TBL] [Abstract][Full Text] [Related]
23. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution.
Lewis JJ; Leung D; Woodruff JM; Brennan MF
Ann Surg; 1998 Sep; 228(3):355-65. PubMed ID: 9742918
[TBL] [Abstract][Full Text] [Related]
24. Aggressive surgery in retroperitoneal soft tissue sarcoma carried out at high-volume centers is safe and is associated with improved local control.
Bonvalot S; Miceli R; Berselli M; Causeret S; Colombo C; Mariani L; Bouzaiene H; Le Péchoux C; Casali PG; Le Cesne A; Fiore M; Gronchi A
Ann Surg Oncol; 2010 Jun; 17(6):1507-14. PubMed ID: 20393803
[TBL] [Abstract][Full Text] [Related]
25. Tumor biology remains the main determinant of prognosis in retroperitoneal sarcomas: a 14-year single-center experience.
Ng DWJ; Tan GHC; Chia CS; Chee SK; Quek R; Farid M; Teo MCC
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e458-e465. PubMed ID: 28371454
[TBL] [Abstract][Full Text] [Related]
26. The impact of postoperative radiological surveillance intensity on disease free and overall survival from primary retroperitoneal, abdominal and pelvic soft-tissue sarcoma.
Glasbey JC; Bundred J; Tyler R; Hunt J; Tattersall H; Gourevitch D; Almond LM; Desai AD; Ford SJ
Eur J Surg Oncol; 2021 Jul; 47(7):1771-1777. PubMed ID: 33549374
[TBL] [Abstract][Full Text] [Related]
27. Prognosis for primary retroperitoneal sarcoma survivors: a conditional survival analysis.
Abbott AM; Habermann EB; Parsons HM; Tuttle T; Al-Refaie W
Cancer; 2012 Jul; 118(13):3321-9. PubMed ID: 22246900
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management.
Heslin MJ; Lewis JJ; Nadler E; Newman E; Woodruff JM; Casper ES; Leung D; Brennan MF
J Clin Oncol; 1997 Aug; 15(8):2832-9. PubMed ID: 9256126
[TBL] [Abstract][Full Text] [Related]
29. Analysis of outcomes and predictors of long-term survival following resection for retroperitoneal sarcoma.
Malinka T; Nebrig M; Klein F; Pratschke J; Bahra M; Andreou A
BMC Surg; 2019 Jun; 19(1):61. PubMed ID: 31182086
[TBL] [Abstract][Full Text] [Related]
30. Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system.
Nathan H; Raut CP; Thornton K; Herman JM; Ahuja N; Schulick RD; Choti MA; Pawlik TM
Ann Surg; 2009 Dec; 250(6):970-6. PubMed ID: 19644351
[TBL] [Abstract][Full Text] [Related]
31. The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients.
Szkandera J; Pichler M; Liegl-Atzwanger B; Absenger G; Stotz M; Ploner F; Stojakovic T; Samonigg H; Eberhard K; Leithner A; Gerger A
J Surg Oncol; 2014 Feb; 109(2):139-44. PubMed ID: 24122271
[TBL] [Abstract][Full Text] [Related]
32. Effect of resection and outcome in patients with retroperitoneal sarcoma.
Chiappa A; Zbar AP; Biffi R; Bertani E; Biella F; Viale G; Pace U; Pruneri G; Orecchia R; Lazzari R; Poldi D; Andreoni B
ANZ J Surg; 2006 Jun; 76(6):462-6. PubMed ID: 16768769
[TBL] [Abstract][Full Text] [Related]
33. Identification of a clinical web-based nomogram to predict overall survival in elderly retroperitoneal sarcoma patients: A population-based study.
Zheng H; Wei J
Medicine (Baltimore); 2022 Sep; 101(39):e30618. PubMed ID: 36181117
[TBL] [Abstract][Full Text] [Related]
34. Contemporary reappraisal of the efficacy of adjuvant chemotherapy in resected retroperitoneal sarcoma: Evidence from a nationwide clinical oncology database and review of the literature.
Datta J; Ecker BL; Neuwirth MG; Geha RC; Fraker DL; Roses RE; Karakousis GC
Surg Oncol; 2017 Jun; 26(2):117-124. PubMed ID: 28577717
[TBL] [Abstract][Full Text] [Related]
35. Impact of histology on survival in retroperitoneal sarcomas.
Brown RE; St Hill CR; Greene QJ; Farmer RW; Reuter NP; Callendar GG; Martin RC; McMasters KM; Scoggins CR
Am J Surg; 2011 Dec; 202(6):748-52; discussion 752-3. PubMed ID: 22030405
[TBL] [Abstract][Full Text] [Related]
36. Recurrent retroperitoneal sarcoma: impact of biology and therapy on outcomes.
Grobmyer SR; Wilson JP; Apel B; Knapik J; Bell WC; Kim T; Bland KI; Copeland EM; Hochwald SN; Heslin MJ
J Am Coll Surg; 2010 May; 210(5):602-8, 608-10. PubMed ID: 20421013
[TBL] [Abstract][Full Text] [Related]
37. Surgical management of primary retroperitoneal sarcoma.
Strauss DC; Hayes AJ; Thway K; Moskovic EC; Fisher C; Thomas JM
Br J Surg; 2010 May; 97(5):698-706. PubMed ID: 20306527
[TBL] [Abstract][Full Text] [Related]
38. Recurrence and survival analysis of resected soft tissue sarcomas of pelvic retroperitoneal structures.
Doepker MP; Hanna KH; Thompson ZJ; Binitie OT; Letson DG; Gonzalez RJ
J Surg Oncol; 2016 Jan; 113(1):103-7. PubMed ID: 26744131
[TBL] [Abstract][Full Text] [Related]
39. Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis.
Nazzani S; Preisser F; Bandini M; Marchioni M; Tian Z; Soulières D; Montanari E; Ratti D; Acquati P; Briganti A; Shariat SF; Abdollah F; Carmignani L; Karakiewicz PI
Eur Urol Oncol; 2018 Sep; 1(4):346-351. PubMed ID: 31100257
[TBL] [Abstract][Full Text] [Related]
40. Applicability of the Sarculator and MSKCC nomograms to retroperitoneal sarcoma prognostication in an Asian tertiary center.
Wong RX; Koh YS; Ong F; Farid M; Tay TKY; Teo M
Asian J Surg; 2020 Nov; 43(11):1078-1085. PubMed ID: 31941593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
